Molecular and mutational profiling in Papillary Thyroid Carcinoma with special emphasis on the influence of BRAFV600E Mutation on Tumor Stage, Outcome and nuclear imaging
21.01.2011
Background: The optimal treatment of papillary thyroid carcinoma (PTC) is still a matter of debate, despite the usually excellent prognosis of patients with this tumor type. Markers are needed to identify patients with high risk of recurrence. The BR...
Klinische Forschung -
21.01.2011 - 30.12.2013
Abgeschlossen
Projektleitung: Broglie Däppen Martina
Mitarbeiter/innen: Stöckli Sandro, Clerici Thomas, Brändle Michael, Bilz Stefan, Müller Joachim, Oettli Rene, Jochum Wolfram, Haile Sarah
Weiter
